Krka's Zyllt Medicine Temporarily Banned in Serbia-Montenegro
Novo Mesto, 6 June - The commercial court in the Serbian city of Novi Sad has temporarily prohibited the sale of the Zyllt drug, manufactured by Slovenian pharma company Krka.
The rest of this news item is available to subscribers.
The news item consists of 927 characters (without spaces) or 169 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.